Ophthalmologists began using laser surgery to correct vision about 25 years ago, and today LASIK and PRK remain among the safest and most effective procedures available.
At the forefront of LASIK and PRK research, physicians at the John A. Moran Eye Center continue to push the field forward. Their most recent study compared two painkillers given to patients following PRK, used for patients who are not ideal candidates for LASIK based on corneal thickness and other factors.
The study, compared oral versus topical nonsteroidal anti-inflammatory drugs. In 157 subjects who took the study medications twice daily, topical ketorolac 0.4% eye drops were more effective than 220 mg oral naproxen.
"This is one of dozens of refractive surgery studies we have completed at Moran over the past 20 years, examining medications, techniques, and devices to produce the best outcomes for our patients," said Mark Mifflin, MD, director of Moran’s Cornea and Refractive Division and chief of surgical services. "Our ongoing efforts in clinical research help keep Moran at the forefront of innovation and best practices, hopefully resulting in better care while moving science forward."